Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark launches AKYNZEO® I.V. in India – First Fixed I.V. Antiemetic Combination for the Prevention of Chemotherapyinduced Nausea and Vomiting’.
The above information is a part of company’s filings submitted to BSE.